CA-125 and Severity of Pre-Eclampsia
试验速览
- 阶段
- 不适用
- 入组人数
- 120
- 主要终点
- increase serum CA-125 in pre-eclamptic patients
研究概览
简要总结
The Aim of this study is to determine the relationship between serum concentrations of cancer antigen-125 (CA-125) and pre-eclampsia severity.
详细描述
Although the source of CA-125 during pregnancy is the fetal chorion, amniotic fluid, and maternal decidua, the perinatal dynamics of maternal serum CA-125 requires clarification. Clinical studies of CA-125 levels and its function in hypertensive pregnant patients are limited and offered contradictory results (Cebesoy et al., 2009).
And so we investigate CA-125 in normal pregnancy and in pre-eclampsia, comparing mild and sever pre-eclampsia to determine relationship of CA-125 and severity of the disease.
Patients will be divided in three groups:
-
Control: 40 normal healthy pregnant women attending the ER in labor.
-
Mild pre-eclampsia: 40 patients fulfilling the following criteria.
-
Blood pressure: systolic blood pressure >140 and <160 , Diastolic blood pressure >90 and <110
-
Proteinuria: 300 mg (+) assessed by urine urignost 3A® (urine strips from DIALAB).
-
No symptoms of severity as headache.
-
Normal investigations for different organ function (as liver and kidney function).
-
Severe pre-eclampsia :40 patients fulfilling anyone or more of the following criteria (The American College of Obstetricians and Gynecologists, 2010)(ACOG):
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Cross Sectional
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Other causes elevate CA-125 as: ovarian cancer, endometrial cancer, breast cancer and benign conditions as: endometriosis and liver cirrhosis.
- •Chronic hypertension
- •Diabetes Mellitus (DM)
- •Liver diseases
- •Thyroid disorders
- •Kidney diseases
- •Cardiac diseases
结局指标
主要结局
increase serum CA-125 in pre-eclamptic patients
时间窗: 1 year
measuring serum CA-125
次要结局
未报告次要终点
研究者
Ahmed Mohamed Bahaa Eldin Ahmed
Clinical professor
Ain Shams Maternity Hospital
